
1. j med virol. 2019 sep;91(9):1684-1687. doi: 10.1002/jmv.25474. epub 2019 apr 13.

routine drug resistance testing proviral hiv-1 dna: prevalence stop codons 
and hypermutation, associated factors.

alidjinou ek(1), deldalle j(1), robineau o(2), hallaert c(1), meybeck a(2),
huleux t(2), ajana f(2), hober d(1), bocket l(1).

author information: 
(1)faculté de médecine, chu lille, laboratoire de virologie ea3610, univ lille,
lille, france.
(2)service universitaire des maladies infectieuses, ch dron, tourcoing, france.

we investigated presence stop codons (sc) and/or hypermutation (hm) in
hiv-1 dna sequences generated routine drug resistance testing proviral
hiv-1 dna, sought associated factors. least one sc identified in
6.2% hiv-1 dna sequences, among 54.8% hypermutated. defective
virus group (sc w/o hm) similar non-sc group regarding the
characteristics hiv-1 infection, drug exposure. addition, the
hiv-1 dna levels different groups. sequences sc/hm
displayed higher proportion rams. impact sc/hm associated rams on
clinical responses requires investigation.

© 2019 wiley periodicals, inc.

doi: 10.1002/jmv.25474 
pmid: 30927451  [indexed medline]

